Xinxiang Ju Yuan Biological Technology Co., Ltd.

Country/Region: China

Main Products: Pharmaceutical Intermediates, Meldrums Acid, Malonic Acid Mono-4-nitrobenzyl Ester, Pharmaceutical Intermediates

Company Introduction
In construction industry we play an important role, given the quality of our pharmaceutical intermediates,Meldrums acid,Malonic acid mono-4-nitrobenzyl ester prevailing in the market. Our production facility was first launched with Above US$100 Million of initial capital and now takes care of Malonic Acid manufacturing with skilled workforce and technologically advanced equipment, as a reputable Manufacturer would do. In addition, we hold Australia,India,South Korea,New Zealand,United Kingdom export share across borders, thanks to our aesthetically appealing and durable Malonic Acid. Xinxiang Ju Yuan Biological Technology Co., Ltd. is a enlisted among top Retailer of Xinxiang, Henan, China, owing to our pharmaceutical intermediates,Meldrums acid,Malonic acid mono-4-nitrobenzyl ester, being top choice in the construction supplies market. Xinxiang Ju Yuan Biological Technology Co., Ltd. LLC (Limited Liability Corp) has reached annual revenue scale across More than 6 Million US Dollar, based on our successful 8 Years of export history. Our product range is specifically designed to level up architecture not only in terms of appeal but also a make that commits years of service. Since, 2012 our products have been remarkable helping us reach a quite fruitful export ratio value estimating around US$2.5 Million - US$5 Million.
Company Overview

Business Type: Manufacturer

Business Nature: Manufacturer

Year Established: 2012, 2012

Legal Status: Agency

Ownership: LLC (Limited Liability Corp)

Employees: 201 - 300 People

Factory Size: 10, 000-30, 000 square meters

R&D Team Size: 51 - 100 People

Certifications: GMP

Contact Information

Contact Person: kelly M

Designation: General Manager

Department: Proprietor

Telephone: 86-373-5071400

Business Information

Main Markets: India (28%) United Kingdom (24%) Australia (22%) South Korea (10%) New Zealand (10%)

Export Focus: Australia, India, South Korea, New Zealand, United Kingdom

Contract Services: Design Service Offered

Trade & Financial Information

Annual Revenue: More than 6 Million US Dollar

Registered Capital: Above US$100 Million

Export Percentage: 91% - 100%

Payment Terms: Bank wire (T/T), Doc Against Acceptance (D/A), Credit Card (CC), Western Union (WU)

Product Showcase
pharmaceutical intermediates
Meldrums acid
Malonic acid mono-4-nitrobenzyl ester
pharmaceutical intermediates

CL-Link > Chemicals, Plastics, and Raw Materials in China Industrial Chemicals & Supplies in China